Pledger GW - Search Results

1

Dezinamide for partial seizures: results of an n-of-1 design trial.

Privitera MD, Treiman DM, Pledger GW, Sahlroot JT, Handforth A, Linde MS, France CR, Cereghino JJ, McCutchen CB, Wood JH. Privitera MD, et al. Among authors: pledger gw. Neurology. 1994 Aug;44(8):1453-8. doi: 10.1212/wnl.44.8.1453. Neurology. 1994. PMID: 8058148 Clinical Trial.

2

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.

Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, Karim R. Privitera M, et al. Neurology. 1996 Jun;46(6):1678-83. doi: 10.1212/wnl.46.6.1678. Neurology. 1996. PMID: 8649569 Clinical Trial.

3

Flunarizine for treatment of partial seizures: results of a concentration-controlled trial.

Pledger GW, Sackellares JC, Treiman DM, Pellock JM, Wright FS, Mikati M, Sahlroot JT, Tsay JY, Drake ME, Olson L, et al. Pledger GW, et al. Neurology. 1994 Oct;44(10):1830-6. doi: 10.1212/wnl.44.10.1830. Neurology. 1994. PMID: 7936231 Clinical Trial.

4

Felbamate for partial seizures: results of a controlled clinical trial.

Leppik IE, Dreifuss FE, Pledger GW, Graves NM, Santilli N, Drury I, Tsay JY, Jacobs MP, Bertram E, Cereghino JJ, et al. Leppik IE, et al. Among authors: pledger gw. Neurology. 1991 Nov;41(11):1785-9. doi: 10.1212/wnl.41.11.1785. Neurology. 1991. PMID: 1944909 Clinical Trial.

5

Design of an individualized fixed-dose clinical trial to test the antiepileptic efficacy of a plasma flunarizine concentration.

Pledger GW, Treiman DM. Pledger GW, et al. Control Clin Trials. 1991 Dec;12(6):768-79. doi: 10.1016/0197-2456(91)90040-s. Control Clin Trials. 1991. PMID: 1665118 Clinical Trial.

6

Increasing plasma concentration tolerability study of flunarizine in comedicated epileptic patients.

Treiman DM, Pledger GW, DeGiorgio C, Tsay JY, Cereghino JJ. Treiman DM, et al. Among authors: pledger gw. Epilepsia. 1993 Sep-Oct;34(5):944-53. doi: 10.1111/j.1528-1157.1993.tb02116.x. Epilepsia. 1993. PMID: 8404751 Clinical Trial.

7

Reanalysis of existing trial data: what can be learned.

Sahlroot JT, Pledger GW. Sahlroot JT, et al. Among authors: pledger gw. Adv Neurol. 1998;76:125-31. Adv Neurol. 1998. PMID: 9408469 Review. No abstract available.

8

Pharmacokinetic and dose tolerability study of ADD 94057 in comedicated patients with partial seizures.

Pledger GW, Laxer KD, Sahlroot JT, Taylor MR, Cereghino JJ, McCormick C, Whitley L, Manning LW. Pledger GW, et al. Epilepsia. 1992 Jan-Feb;33(1):112-8. doi: 10.1111/j.1528-1157.1992.tb02292.x. Epilepsia. 1992. PMID: 1733743 Clinical Trial.

9

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

Elterman RD, Glauser TA, Wyllie E, Reife R, Wu SC, Pledger G. Elterman RD, et al. Neurology. 1999 Apr 22;52(7):1338-44. doi: 10.1212/wnl.52.7.1338. Neurology. 1999. PMID: 10227615 Clinical Trial.

10

Dosage adjustments in response to monitored plasma concentrations: can unblinded staff adhere to objective criteria?

Sahlroot JT, Pledger GW. Sahlroot JT, et al. Among authors: pledger gw. J Biopharm Stat. 1994 Mar;4(1):91-100. doi: 10.1080/10543409408835074. J Biopharm Stat. 1994. PMID: 8019586 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page